Year: 2020

Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual Capital Markets Day on November 24, 2020. Focus of the day will be on the new direction for the company with emphasis on its fully owned assets tasquinimod andlaquinimod. Company management and international experts will present the current status and development plans for the project.Live Q&A webcast The virtual event consists of presentations from Active Biotech executives and international expertsfollowed by a live Q&A webcast. The presentations will be available on Active Biotech’s websitewww.activebiotech.com on November 24 at 08:00 CET.The livestreamed Q&A webcast will take place on November 24 from 14:00-15:00 CET. A recording of the Q&A webcast will be published on Active Biotech’s website after the event.All...

Active Biotech AB (publ) (ticker: ACTI) inbjuder härmed analytiker, investerare och media till sin virtuella kapitalmarknadsdag den 24 november 2020. Dagens fokus kommer att vara på bolagets nya inriktning med betoning på de helägda projekten tasquinimod och laquinimod. Företagsledning och internationella experter kommer att presentera aktuell status och utvecklingsplaner för projekten. Direktsänd frågestund Den virtuella kapitalmarknadsdagen består av presentationer från företagsledningen och internationella experter följt av en direktsänd frågestund. Presentationerna kommer att vara tillgängliga på Active Biotechs hemsida www.activebiotech.com den 24 november kl. 8:00.Den direktsända frågestunden hålls den 24 november kl. 14:00-15:00. En inspelning av fråge-stunden kommer att finnas tillgänglig i efterhand på Active Biotechs hemsida.Samtliga...

In the first half of 2020, the Jotul Group reached a consolidated profit of MNOK -68.5 (H12019: MNOK -46.9). The operating result totaled MNOK -60.1 in H1 2020 (H1 2019: MNOK -16.7). The 2020 total comprehensive loss for the half-year was MNOK -52.3 (H1 2019: MNOK -54.1).Sales for the period declined by 6% (MNOK 360.4 in H1 2020 vs. MNOK 383.6 in H1 2019), mainly driven from an unseasonal warm weather and low energy prices as well as initial start-up capacity from the new production facility in Poland. In addition, the COVID-19 impact in the second quarter contributed to a decline of approximately 8%, significantly less than previously anticipated. The decline in sales derives with no large variations from the main markets, with the exception of North America which saw a decline of approximately 18%. Order intake in the period is slightly...

CALGARY, Alberta, Nov. 06, 2020 (GLOBE NEWSWIRE) — Saturn Oil & Gas Inc. (“Saturn” or the “Company”) (TSX.V: SOIL) (FSE: SMK) is pleased to announce that Jean-Pierre Colin has joined the team as Strategy Consultant to John Jeffrey, CEO, and the Company’s Board of Directors.Jean-Pierre Colin (“JP Colin”) brings 40 years of investment banking and corporate governance knowledge as a Strategy Consultant to numerous high-profile Canadian and international publicly-listed resource and technology companies. He was advisor to some of the uppermost senior political figures within the Canadian Federal Government and the Privy Council of Canada through five of Petro-Canada’s acquisitions of the country’s then largest oil & gas corporations in the 1980’s. Subsequently, his firm served as lead underwriter of...

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces the appointment of Investec Bank plc as joint corporate broker, with immediate effect to work alongside its existing nominated adviser and joint broker, Stifel.For further information, please contact:About Kidney Disease Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally. The Centers for Disease Control and Prevention (CDC) estimates that 15% of US adults, or 37 million people, currently have chronic kidney disease (CKD).  Further, the CDC reports that 9 out of 10 adults with CKD do not know they...

The Company achieved a significant milestone with its Zero Trust ZoneZero™ solution deployed by multiple Asian leading channels ready to market it to their customersHERZLIYA, Israel, Nov. 06, 2020 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments, today announced the release of Safe-T’s ZoneZero™ version 4.4, the only Zero Trust Network Access (ZTNA) solution in the market which unifies all access scenarios for internal and external users.Organizations today face a wide range of Zero Trust access scenarios and requirements, all of which must be addressed by the organizations’ IT and security teams:Control and secure remote access to resources for external VPN users (remote employees) and non-VPN users (WFH, contractors, and more).Control...

TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its Port Perry Facility’s preliminary outdoor cannabis harvest results, where 50,000 plants have yielded approximately 31,200 kgs of dried cannabis flower at a cash cost per gram to harvest of $0.10.“The 2020 harvest is a major step forward from our previous year’s results. It also represents a shift in focus, from producing extractable biomass, towards high quality dried flower tailored to adult-use consumers,” said Aleafia Health CEO Geoffrey Benic. “An expanded dried flower offering is a key component of our product portfolio’s broader expansion. Along with many new, innovative Cannabis 2.0 launches in the near term, this marks an incredibly exciting growth period for Aleafia Health.”Expansion...

OTTAWA, Ill., Nov. 06, 2020 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for Ottawa Savings Bank, FSB (the “Bank”), announced net income of $0.8 million, or $0.27 per basic and diluted common share for the three months ended September 30, 2020, compared to net income of $0.5 million, or $0.18 per basic and diluted common share for the three months ended September 30, 2019. For the nine months ended September 30, 2020, the Company announced net income of $1.6 million, or $0.55 per basic and diluted common share, compared to net income of $1.4 million, or $0.44 per basic and diluted common share for the nine months ended September 30, 2019. During the third quarter of 2020, the Company experienced an increase in loan originations which drove growth in the loan portfolio. The loan portfolio,...